47
Views
4
CrossRef citations to date
0
Altmetric
Immunology

A multi‐centre evaluation of the intra‐assay and inter‐assay variation of commercial and in‐house anti‐cardiolipin antibody assays

, , , , , , , , , , & show all
Pages 182-192 | Received 08 Aug 2003, Accepted 15 Dec 2003, Published online: 06 Jul 2009

References

  • Harris EN, Pierangeli SS. Revisiting the anticardiolipin test and its standardization. Lupus 2002; 11: 269–75.
  • Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am JPathol2002; 118: 548–57.
  • Robert JM, Macara LM, Chalmers EA, Smith GC. Inter-assay variation in antiphospholipid antibody testing. BJOG 2002; 109: 348–9.
  • Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphos-pholipid Forum. Thromb Haemost 2001; 86: 575–83.
  • Fontaine M, Homburger HA, Nichols WL. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Thromb Haemost 2001; 86: 1123–4.
  • Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999; 31: 142–7.
  • Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995; 73: 444–52.
  • Coulam CB, McIntyre JA, Wagenknecht D, Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet 1990; 335: 865.
  • Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827–32.
  • Wong RCW, Gillis D, Adelstein S, et al. Consensus guidelines on anti-cardiolipin antibody testing and reporting. Pathology 2004; 36: 63–8.
  • Wong RCW, Wilson RJ, Pollock W, Steele RH, Gillis D. Anti-cardiolipin antibody testing and reporting practices among labora-tories participating in a large external Quality Assurance Program. Pathology 2004; 36: 174–181.
  • Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphos-pholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309–11.
  • Triplett DA. Antiphospholipid antibodies. Arch Pathol Lab Med 2002; 126: 1424–9.
  • Greaves M, Cohen H, MacHin Si, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000; 109: 704–15.
  • Lockshin MD, Sammaritano LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43: 440–3.
  • Harris EN, Gharavi AE, Patel S, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986. Clin Exp Immunol 1987; 68: 215–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.